Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Two-Part Study to Evaluate the Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension

NCT07511361 is registered in ClinicalTrials.gov with Kardigan, Inc. as lead sponsor.

NCT NCT07511361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07511361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Two-Part Study to Evaluate the Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
Lead sponsor
Kardigan, Inc.
Phase
Phase 2
Overall status
Recruiting
Start date
June 23, 2026
Completion date
February 28, 2027
Enrollment
140 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

acute severe hypertension, hypertension, hypertensive emergency, hypertensive urgency